Reneo Pharmaceuticals CEO Gregory Flesher's 2022 pay falls 78% to $1.2M
Reneo Pharmaceuticals reports 2022 executive compensation
By ExecPay News
Published: April 26, 2023
Reneo Pharmaceuticals reported fiscal year 2022 executive compensation information on April 26, 2023.
In 2022, three executives at Reneo Pharmaceuticals received on average a compensation package of $933K, a 68% decrease compared to previous year.
Average pay of disclosed executives at Reneo Pharmaceuticals
Gregory J. Flesher, Chief Executive Officer, received $1.2M in total, which decreased by 78% compared to 2021. 46% of Flesher's compensation, or $545K, was in salary. Flesher also received $245K in non-equity incentive plan, $393K in option awards, as well as $10K in other compensation.
Ashley F. Hall, Chief Development Officer, received a compensation package of $825K. 51% of the compensation package, or $420K, was in salary.
Michael P. Cruse, Chief Operating Officer, earned $781K in 2022, a 48% decrease compared to previous year.
Related executives
You may also like
Source: SEC filing on April 26, 2023.